Literature DB >> 5917865

[First observations on an antihypertensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in man].

D Michel, W Zimmermann, A Nassehi, P Seraphim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5917865     DOI: 10.1055/s-0028-1111550

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  8 in total

1.  The central action of clonidine and its antagonism.

Authors:  F Katic; H Lavery; R D Lowe
Journal:  Br J Pharmacol       Date:  1972-04       Impact factor: 8.739

2.  [The cardiovascular effect of regitine in normal pregnancy].

Authors:  U Retzke; R Schwarz
Journal:  Arch Gynakol       Date:  1968

3.  [Influence of dichlorphenylaminoimidazoline (Catapresan) on alveolar ventilation and short-circuit perfusion of the lung].

Authors:  M Stauch
Journal:  Klin Wochenschr       Date:  1968-05-01

4.  [On a new hypertensive agent with predominant central action, 2-(2,6-dichlorophenylamino)-2-imidazolinhydrochloride (St 155)].

Authors:  P A van Zwieten
Journal:  Klin Wochenschr       Date:  1968-01-15

5.  Pharmacokinetics and side-effects of clonidine.

Authors:  A Keränen; S Nykänen; J Taskinen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

6.  Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system.

Authors:  R Laverty; K M Taylor
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

7.  Treatment of hypertension with clonidine.

Authors:  A I MacDougall; G J Addis; N MacKay; I W Dymock; A G Turpie; D L Ballingall; W J MacLennan; B Whiting; J G MacArthur
Journal:  Br Med J       Date:  1970-08-22

8.  Hypotensive action and side-effects of flutonidin in normal subjects. A double-blind controlled trial.

Authors:  P Sala; S M Chierichetti; P Ferrari
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.